SYNELVIA
  • About Us
  • Services
    • Analytical services
    • Innovative models and solutions
    • Imaging services
    • Scientific support
  • Scientific Ressources
    • R&D programs
    • Publications
    • Posters
  • Fields of interest
    • Dermo-cosmetic
    • Early drug development
  • Contact

Publications

A frequent functional SNP in the MMP-1 promoter is associated with a higher disease severity in Recessive Dystrophic Epidermolysis Bullosa.

#
2015-12-01
Love0

Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosa.

#
2015-12-01
Love0

Black Patients of African descent and HLA-DRB*1503 frequency Overrepresented in a French Cohort of Epidermolysis Bullosa Acquisita.

#
2015-12-01
Love0

Deimination of human filaggrin-2 promotes its proteolysis by calpain 1.

#
2015-12-01
Love0

siRNA-mediated allele-specific inhibition of mutant type VII collagen in dominant dystrophic epidermolysis bullosa.

#
2015-12-01
Love0

Knockdown of filaggrin in a three-dimensional reconstructed human epidermis impairs keratinocyte differentiation.

#
2015-12-01
Love0

In a three-dimensional reconstructed human epidermis filaggrin-2 is essential for proper cornification.

#
2015-12-01
Love0

Defects of corneocyte structural proteins and epidermal barrier in atopic dermatitis.

By SynelviaPublications, Scientific resources

Le Lamer M, Pellerin L, Reynier M, Cau L, Pendaries V, Leprince C, Méchin MC, Serre G, Paul C, Simon M. Defects of corneocyte structural proteins and epidermal barrier in atopic dermatitis. Biol Chem. 2015 Jun 26

Read More
2015-11-27
Love0

SYNELVIA

Independent Contract Research organization
specialized in the evaluation
of drug & molecules effects
using innovative technologies
within a regulatory framework.

NEWS

  • Study of the antioxidant effect of White Plus Serum on UVs irradiated skin explants
  • Evaluation of the Anti infra-red protection of cosmetic products, In Vivo
  • Biochemical exploration of the cutaneous response of ultraviolet irradiation on a skin explant model

© 2021 SYNELVIA. SAS Legal mentions

  • About Us
  • Services
    • Analytical services
    • Innovative models and solutions
    • Imaging services
    • Scientific support
  • Scientific Ressources
    • R&D programs
    • Publications
    • Posters
  • Fields of interest
    • Dermo-cosmetic
    • Early drug development
  • Contact